| RRC ID |
69647
|
| Author |
Harada A, Matsumoto S, Yasumizu Y, Shojima K, Akama T, Eguchi H, Kikuchi A.
|
| Title |
Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion.
|
| Journal |
Elife
|
| Abstract |
Pancreatic cancer has a high mortality rate due to metastasis. Whereas KRAS is mutated in most pancreatic cancer patients, controlling KRAS or its downstream effectors has not been succeeded clinically. ARL4C is a small G protein whose expression is induced by the Wnt and EGF-RAS pathways. In the present study, we found that ARL4C is frequently overexpressed in pancreatic cancer patients and showed that its localization to invasive pseudopods is required for cancer cell invasion. IQGAP1 was identified as a novel interacting protein for ARL4C. ARL4C recruited IQGAP1 and its downstream effector, MMP14, to invasive pseudopods. Specific localization of ARL4C, IQGAP1, and MMP14 was the active site of invasion, which induced degradation of the extracellular matrix. Moreover, subcutaneously injected antisense oligonucleotide against ARL4C into tumor-bearing mice suppressed metastasis of pancreatic cancer. These results suggest that ARL4C-IQGAP1-MMP14 signaling is activated at invasive pseudopods of pancreatic cancer cells.
|
| Volume |
10
|
| Published |
2021-9-30
|
| DOI |
10.7554/eLife.66721
|
| PII |
66721
|
| PMID |
34590580
|
| PMC |
PMC8598236
|
| MeSH |
ADP-Ribosylation Factors / genetics*
ADP-Ribosylation Factors / metabolism
Aged
Aged, 80 and over
Animals
Female
Gene Expression Regulation, Neoplastic*
Humans
Male
Mice
Middle Aged
Neoplasm Invasiveness / genetics*
Pancreatic Neoplasms / genetics*
Proto-Oncogene Proteins p21(ras) / genetics*
Proto-Oncogene Proteins p21(ras) / metabolism
Pseudopodia / physiology*
Tumor Cells, Cultured
|
| IF |
7.08
|
| Resource |
| Human and Animal Cells |
PANC-1(RCB2095) |
| DNA material |
CSII-CMV-MCS-IRES2-Bsd (RDB04385) |
